TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish Biomedical Consulting AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3
|
23
|
16 |
| Financial expenses |
0
|
4
|
0 |
| Earnings before taxes |
27
|
10
|
7 |
| EBITDA |
-4
|
14
|
7 |
| Total assets |
65
|
39
|
33 |
| Current assets |
65
|
39
|
33 |
| Current liabilities |
30
|
21
|
23 |
| Equity capital |
35
|
18
|
10 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
53.8%
|
46.2%
|
30.3% |
| Turnover per employee |
3
|
23
|
16 |
| Profit as a percentage of turnover |
900%
|
43.5%
|
43.8% |
| Return on assets (ROA) |
41.5%
|
35.9%
|
21.2% |
| Current ratio |
216.7%
|
185.7%
|
143.5% |
| Return on equity (ROE) |
77.1%
|
55.6%
|
70.0% |
| Change turnover |
-20
|
9
|
16 |
| Change turnover % |
-88%
|
62% | |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.